Aura Biosciences
AURA
44 hedge funds and large institutions have $224M invested in Aura Biosciences in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 5 reducing their positions, and 0 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 5
26% more funds holding
Funds holding: 35 → 44 (+9)
6.91% more ownership
Funds ownership: 47.06% → 53.98% (+6.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less capital invested
Capital invested by funds: $300M → $224M (-$76M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$10.1M |
| 2 |
RCM
Regency Capital Management
Honolulu,
Hawaii
|
+$4.21M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.42M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.84M |
| 5 |
Citigroup
New York
|
+$2.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$338K |
| 2 |
Barclays
London,
United Kingdom
|
-$290K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$74.4K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$13.1K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
AURA Hedge Fund Activity: Q2 2022 in Review
44 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q2 2022, worth a combined $224M — down 25% from $300M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new AURA positions and 0 closed out — a net gain of 10 holders — while 25 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $10.1M. The largest seller was Adage Capital Partners, cutting an estimated $338K.
- 44 institutional investors held Aura Biosciences (AURA) as of Q2 2022, up from 35 in Q1 2022.
- Funds reported $224M of Aura Biosciences stock for Q2 2022, down 25% quarter-over-quarter.
- 10 funds opened new Aura Biosciences positions in Q2 2022 and 0 closed out, a net change of +10 holders.
- The largest Aura Biosciences buyer in Q2 2022 was BlackRock, an estimated $10.1M added.
- The largest Aura Biosciences seller in Q2 2022 was Adage Capital Partners, an estimated $338K sold.
Based on aggregated 13F filings for Q2 2022.